Clinical Safety and Efficacy of Hydrophilic Acrylic Intraocular Lenses

NCT03145103 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 282

Last updated 2018-07-18

No results posted yet for this study

Summary

Clinical safety and efficacy of CT ASPHINA 409 IOLs after implantation

Conditions

  • Cataract

Interventions

DEVICE

CT ASPHINA 409

intraocular lens

Sponsors & Collaborators

  • Carl Zeiss Meditec AG

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-07
Primary Completion
2018-06-26
Completion
2018-06-26

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03145103 on ClinicalTrials.gov